Abstracts

Cognitive Reserve and Neuropsychological Functioning in Older HIV-Infected People

Background: Progress in treatments has led to HIV-infected patients getting older. Both age and HIV are risk factors for cognitive decline. We explored the role of cognitive reserve (CR) to the maintenance of neuropsychological integrity in older HIV-infected people. Methods: We performed a multicenter study, consecutively enrolling asymptomatic HIV+ patients ≥60 years old during routine…

Mitochondrial DNA, Neurologic and Systemic Inflammation, and Immune Dysregulation

Background: We recently found that higher levels of cell-free mtDNA in cerebrospinal fluid (CSF) were associated with more neurological and systemic inflammation in a clinically heterogeneous cohort of HIV infected individuals. Here we investigated how CSF mtDNA levels relate to inflammation and immune status in a cohort of virologically suppressed individuals, and in 5 individuals…

CSF Metabolomics Implicate Bioenergetic Adaptation as a Neural Mechanism Regulating Shifts in the Cognitive States of HIV-Infected Subjects

Background: Although combinational antiretroviral therapy (ART) has been an effective tool in controlling replication of the Human Immunodeficiency Virus (HIV), ART has not been completely effective to suppress neurological complications. While some cases of cognitive impairment can be attributed to ART failure, many individuals develop HIV-Associated Neurocognitive Disorders (HAND) with stable ART, little or no…

Altered Monoamine and Acylcarnitine Metabolites in HIV Patients with Depression

Background: Depression is a frequent comorbidity in HIV infection and an important predictor of poor treatment outcomes and increased mortality. Accumulating evidence suggests that inflammation and increased tryptophan catabolism are associated with increased risk of developing major depressive disorder in HIV infection, but the mechanisms leading to depression remain poorly understood. Methods: The severity of…

Mitochondrial Injury and Cognitive Function in HIV Infection and Methamphetamine

Background: Mitochondria carry their genome and are critical in providing energy for cellular processes in the central nervous system (CNS). Damage to mitochondrial DNA (mtDNA) is associated with many neurodegenerative diseases. HIV infection and methamphetamine (METH) abuse, a common comorbidity, can cause damage to mtDNA and subsequently lead to neurocognitive morbidity. Here we evaluated the…

Efavirenz-Induced Nitric Oxide Affects Mitochondrial Function in Glial Cells

Background: Neurological pathogenesis is closely associated with mitochondria. Nitric oxide (NO) is a ubiquitous central nervous system (CNS) mediator implicated in both mitochondrial dysfunction and inflammation. More than 50% of Efavirenz (EFV)-treated patients exhibit CNS-related effects that often require discontinuation of the therapy; moreover this drug has been recently linked to the development of HIV-associated…

Role of HIV Strain, Accessory Proteins, and Cytokines in Macrophage HO-1 Deficiency

Background: Protein expression of the cytoprotective enzyme heme oxygenase-1 (HO-1) is reduced in the prefrontal cortex of HIV+ individuals and negatively correlates with CNS viral replication and neuroinflammation. HIV infection of monocyte-derived macrophages (MDM) reduces HO-1 protein expression and pharmacologic rescue of HO-1 expression ameliorates HIV-MDM neurotoxin production. We now present data describing the change…

Atorvastatin Reverses the HIV-induced HO-1 Defect in Primary Human Macrophages

Background: HIV-associated neurocognitive disorders (HAND) are a collection of neurological deficits characterized by cognitive, motor, and behavior abnormalities, and remains a significant problem in ART-treated infected individuals. Neurological injury in HAND is a consequence of both persistent immune activation and the release of neurotoxins, such as glutamate, by HIV-infected and/or activated macrophages and microglia. Previous…